Sublingual immunotherapy in allergic rhinitis and asthma in 2-5 year-old children sensitized to acarus;Inmunoterapia sublingual en rinitis alérgica y asma en niños de dos a cinco años sensibilizados con ácaros

Revista Alergia Mexico

Volumn 55, Issue 2, 2008, Pages 71-75

  Santos, Olimpio Rodríguez ^a,b,c  

^a Policlínico Universitario Docente Previsora

^b Edificio D ^*

^c Edificio D   (Cuba)

Author keywords

Acarus; Allergic rhinitis; Asthma; Efficacy; Safety; Sublingual immunotherapy

Indexed keywords

ALLERGEN; CORTICOSTEROID; IMMUNOMODULATING AGENT;

ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOMIA TROPICALIS; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRICK TEST; RISK FACTOR;

EID: 70849130483     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Martínez B, Ayala Mejías S, Molina Quirós C, Colmenero Ruiz M, Sanz Fernández R. Inmunoterapia sublingual en la rinitis alérgica estacional. Revisión en 30 pacientes. Acta Otorrinolaringol Esp 2005;56:112-5.
2. Frati F, Sensi L, Di Rienzo V, Senna GE, Incorvaia C, Marcucci F. A model for management of sublingual immunotherapy. Allerg Immunol (Paris) 2003;35(2):56-60.
3. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111(3):437-48.
4. Madonini E, Agostinis F, Barra R, Berra A, Donadio D, Pappacoda A, Stefani E, Tierno E. Long-term and preventive effects of sublingual allergen-specific immunotherapy: a retrospective, multicentric study. Int J Immunopathol Pharmacol 2003;16(1):73-79.
5. Alergia a ácaros domésticos. Disponible en: http://www.biocen.cu/
6. Información para médicos. Disponible en: http://www.biocen.cu/
7. Schmidt Weber CB, Blaser K. T-cell tolerance in allergic response. Allergy 2002;(57):762-8.
8. Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33(2):206-10.
9. Silvestri M, Spallarossa D, Battistini E, Sabatini F, et al. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. J Invest Allergol Clin Immunol 2002;12(1):52-59.
10. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18(5):277-84.
11. Passalacqua G, Canonica GW. Allergen-specific sublingual immunotherapy for respiratory allergy. BioDrugs 2001;15(8):509-19.
12. Bahçeciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001;32(1):49-55.
13. Frew AJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001;107(3):441-4.
14. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55(9):842-9.
15. Guez S, Vatrinet C, Fadel R, André C. House dust mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55(4):369-75.
16. André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121(3):229-34.
17. Mungan D, Misirligil Z, Gürbüz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma - a placebo controlled study. Ann Allergy Asthma Immunol 1999;82(5):485-90.
18. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54(3):249-60.
19. Passalacqua G, Albano M, Fregonese L, Riccio A, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351(9103):629-32.
20. Hirsch T, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8(1):21-27.
21. Almagro E, Asensio O, Bartolomé JM, Bosque M y col. Estudio multicéntrico de farmacovigilancia de inmunoterapia sublingual en pacientes alérgicos. Allergol Immunopathol (Madr) 1995;23(4):153-9.
22. Tari MG, Mancino M, Madonna F, Buzzoni L, Parmiani S. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 1994;22(5):209-16.
23. Rodríguez Santos OR, Rodríguez VM. Asma bronquial en niños. Inmunoterapia sublingual con Dermatophagoides pteronyssinus como alternativa de tratamiento. Ciencia Pediatrika 2005;25(6):18-21.
24. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
25. Wilson DR, Torres Lima M, Durham SR. Inmunoterapia sublingual para la rinitis alérgica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, número 4, 2006. Oxford, Update Software Ltd. Disponible en: http://www.update-software.com.
26. (Traducida de The Cochrane Library, 2006 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).